Brian joined us in 2000. Prior to joining us, he worked in Institutional Sales at Adams Harkness & Canaccord Genuity. Brian has been a Managing Director in Equity Capital Markets since 2008, where he has executed transactions across Growth Sectors. He started his career at The Boston Company. Brian holds a BA in English Language and Literature from The College of the Holy Cross.
Selected Transactions
-
US$18m
Sundial Growers, Inc.
Joint Agent (Private Placement)
-
US$35m
Misonix
Sole Bookrunner (Follow-on Offering)
-
US$98m
SeaSpine
Joint Bookrunner (Follow-On)
-
US$25m
RADA Electronic Industries LTD.
Bookrunner (Follow-On)
-
US$74m
Aptose Biosciences Inc.
Bookrunner (Follow-on Offering)
-
US$75m
Neoleukin Therapeutics, Inc.
Lead Manager (Follow-On Offering)
-
US$58m
Alphatec Holdings, Inc.
Joint Bookrunner (CMPO)
-
US$30m
Sesen Bio Inc.
Sole Bookrunner (CMPO)
-
US$26m
Sharpspring
Joint Bookrunner (Secondary Public Offering)